An open label, single-center pilot study of early conversion from tacrolimus to efalizumab maintenance therapy in primary renal transplant recipients
Phase of Trial: Phase I/II
Latest Information Update: 25 Nov 2014
At a glance
- Drugs Efalizumab (Primary) ; Mycophenolate mofetil; Prednisone
- Indications Renal transplant rejection
- Focus Therapeutic Use
- 05 Dec 2012 Primary endpoint added as reported by ClinicalTrials.gov.
- 26 May 2010 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov.
- 20 Nov 2007 Status changed from initiated to recruiting.